Seshu Tyagarajan, Chief Technology Officer at Candel Therapeutics, Inc. (CADL), sold 29,090 shares at $8.22 ($239K) on 2025-01-08, disclosed to the SEC on 2025-01-10.
Open-market sale of $239k CADL by Chief Technology Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.22 | 14,545 | $120K | 50.0% |
| 2 | $8.22 | 14,545 | $120K | 50.0% |
| Total | $8.22 avg | 29,090 | $239K | 100% |
| Filing → |
| CADL | SELL | 2025-03-20 | $552K | — | Filing → |
| CADL | SELL | 2025-01-17 | $207K | — | Filing → |
| CADL | SELL | 2024-12-03 | $186K | — | Filing → |